AAAAAA

   
Results: 1-14 |
Results: 14
Insurance reimbursement for risk-reducing mastectomy and oophorectomy in women with BRCA1 or BRCA2 mutations
Authors: Kauff, ND Scheuer, L Robson, ME Glogowski, E Kelly, B Barakat, R Heerdt, A Borgen, PI Davis, JG Offit, K
Citation: Nd. Kauff et al., Insurance reimbursement for risk-reducing mastectomy and oophorectomy in women with BRCA1 or BRCA2 mutations, GENET MED, 3(6), 2001, pp. 422-425
A single nucleotide polymorphism in the 5 ' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers
Authors: Wang, WW Spurdle, AB Kolachana, P Bove, B Modan, B Ebbers, SM Suthers, G Tucker, MA Kaufman, DJ Doody, MM Tarone, RE Daly, M Levavi, H Pierce, H Chetrit, A Yechezkel, GH Chenevix-Trench, G Offit, K Godwin, AK Struewing, JP
Citation: Ww. Wang et al., A single nucleotide polymorphism in the 5 ' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers, CANC EPID B, 10(9), 2001, pp. 955-960
The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations
Authors: Satagopan, JM Offit, K Foulkes, W Robson, ME Wacholder, S Eng, CM Karp, SE Begg, CB
Citation: Jm. Satagopan et al., The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations, CANC EPID B, 10(5), 2001, pp. 467-473
Risk of endometrial carcinoma associated with BRCA mutation
Authors: Levine, DA Lin, O Barakat, RR Robson, ME McDermott, D Cohen, L Satagopan, J Offit, K Boyd, J
Citation: Da. Levine et al., Risk of endometrial carcinoma associated with BRCA mutation, GYNECOL ONC, 80(3), 2001, pp. 395-398
Prophylactic mastectomy in carriers of BRCA mutations
Authors: Offit, K Robson, M Schrag, D
Citation: K. Offit et al., Prophylactic mastectomy in carriers of BRCA mutations, N ENG J MED, 345(20), 2001, pp. 1498-1499
T beta R-I(6A) association with colorectal cancer: A new twist? Reply
Authors: Pasche, B Bian, Y Reich, J Rademaker, A Kolachana, P Offit, K
Citation: B. Pasche et al., T beta R-I(6A) association with colorectal cancer: A new twist? Reply, CANCER RES, 61(22), 2001, pp. 8351-8352
Participation in the cooperative family registry for breast cancer studies: Issues of informed consent
Authors: Daly, MB Offit, K Li, F Glendon, G Yaker, A West, D Koenig, B McCredie, M Venne, V Nayfield, S Seminara, D
Citation: Mb. Daly et al., Participation in the cooperative family registry for breast cancer studies: Issues of informed consent, J NAT CANC, 92(6), 2000, pp. 452-456
Are BRCA1- and BRCA2-associated breast cancers different?
Authors: Offit, K
Citation: K. Offit, Are BRCA1- and BRCA2-associated breast cancers different?, J CL ONCOL, 18(21), 2000, pp. 104S-106S
Genetic prognostic markers for colorectal cancer
Authors: Offit, K
Citation: K. Offit, Genetic prognostic markers for colorectal cancer, N ENG J MED, 342(2), 2000, pp. 124-125
Absence of premalignant histologic, molecular, or cell biologic alterations in prophylactic oophorectomy specimens from BRCA1 heterozygotes
Authors: Barakat, RR Federici, MG Saigo, PE Robson, ME Offit, K Boyd, J
Citation: Rr. Barakat et al., Absence of premalignant histologic, molecular, or cell biologic alterations in prophylactic oophorectomy specimens from BRCA1 heterozygotes, CANCER, 89(2), 2000, pp. 383-390
The exon 13 duplication in the BRCA1 gene is a founder mutation present ingeographically diverse populations
Authors: Mazoyer, S Leary, J Kirk, J Fleischmann, E Wagner, T Claes, K Messiaen, L Foulkes, W Desrochers, M Simard, J Phelan, CM Kwan, E Narod, SA Vahteristo, P Nevanlinna, H Durando, X Bignon, YJ Peyrat, JP Bonnardel, C Sinilnikova, OM Puget, N Lenoir, GM Mazoyer, S Audoynaud, C Goldgar, D Maugard, C Caux, V Gad, S Stoppa-Lyonnet, D Nogues, C Lidereau, R Machavoine, C Bressac-de Paillerets, B Kuschel, B Betz, B Niederacher, D Beckmann, MW Hamann, U Gayther, SA Ponder, BAP Robinson, M Taylor, GR Bishop, T Catteau, A Solomon, E Cohen, B Steel, M Collins, N Stratton, M van der Looij, M Olah, E Miller, NJ Barton, DE Sverdlov, RS Friedman, E Radice, P Montagna, M Sensi, E Caligo, M van Eijk, R Devilee, P van der Luijt, R Heimdal, K Moller, P Borg, A Diez, O Cortes, J Domenech, M Baiget, M Osorio, A Benitez, J Borg, A Maillet, P Sappino, AP Ozdag, H Ozcelik, T Ozturk, M Rohlfs, EM Boyd, J McDermott, D Offit, K Unger, M Nathanson, K Weber, BL Sellers, TA Hampton, E Couch, FJ Neuhausen, S
Citation: S. Mazoyer et al., The exon 13 duplication in the BRCA1 gene is a founder mutation present ingeographically diverse populations, AM J HU GEN, 67(1), 2000, pp. 207-212
Breast conservation therapy for invasive breast cancer in Ashkenazi women with BRCA gene founder mutations
Authors: Robson, M Levin, D Federici, M Satagopan, J Bogolminy, F Heerdt, A Borgen, P McCormick, B Hudis, C Norton, L Boyd, J Offit, K
Citation: M. Robson et al., Breast conservation therapy for invasive breast cancer in Ashkenazi women with BRCA gene founder mutations, J NAT CANC, 91(24), 1999, pp. 2112-2117
Breast cancer: New paradigms
Authors: Offit, K
Citation: K. Offit, Breast cancer: New paradigms, J CLIN LIG, 22(2), 1999, pp. 217-220
T beta R-I(6A) is a candidate tumor susceptibility allele
Authors: Pasche, B Kolachana, P Nafa, K Satagopan, J Chen, YG Lo, RS Brener, D Yang, D Kirstein, L Oddoux, C Ostrer, H Vineis, P Varesco, L Jhanwar, S Luzzatto, L Massague, J Offit, K
Citation: B. Pasche et al., T beta R-I(6A) is a candidate tumor susceptibility allele, CANCER RES, 59(22), 1999, pp. 5678-5682
Risultati: 1-14 |